首页DEMG • LON
add
Deltex Medical Group plc
市场资讯
财务信息
损益表
收入
净收入
(GBP) | 2024年6月info | 年同比变化 |
---|---|---|
收入 | 53.20万 | 0.47% |
经营支出 | 57.65万 | 0.70% |
净收入 | -27.30万 | -1.68% |
净利润率 | -51.32 | -1.20% |
每股收益 | — | — |
息税折旧摊销前利润 | -20.15万 | -6.33% |
有效税率 | — | — |
资产负债表
总资产
负债总额
(GBP) | 2024年6月info | 年同比变化 |
---|---|---|
现金及短期投资 | 32.60万 | 204.67% |
总资产 | 550.00万 | -7.47% |
负债总额 | 281.20万 | -31.48% |
权益总额 | 268.80万 | — |
发行在外的股份 | 18.92亿 | — |
市净率 | ∞ | — |
资产回报率 | -10.05% | — |
资本回报率 | -11.83% | — |
现金流
现金净变动
(GBP) | 2024年6月info | 年同比变化 |
---|---|---|
净收入 | -27.30万 | -1.68% |
来自运营的现金 | -21.75万 | -42.62% |
投资现金 | 1000.00 | 100.83% |
融资现金 | 2.15万 | -77.37% |
现金净变动 | -18.95万 | -4.12% |
自由现金流 | -11.31万 | 53.54% |
简介
Deltex Medical Group is a medical technology company based in Chichester that produces blood monitoring and fluid management equipment for use in surgical operations.
It has sold 3000 of its main product, the ultrasound probe CardioQ-ODM, which measures the rate of blood flow from the heart. The company claims that it has been shown to reduce postoperative complications and reduce length of hospital stay. According to the National Institute for Health and Care Excellence it could save £1000 per operation and could be used on more than 800,000 patients a year. As it is inserted into the gullet, it reduces the risk of infection that comes with monitoring using a tube inserted through a vein into the heart. Each probe costs about £100.
It secured approval from the NHS Supply Chain in 2012 after a tender process, to sell cardiac output monitoring equipment to the NHS in England, meaning that individual NHS trusts did not have to go through a tender process. In November 2016 an NHS hospital bought six, the largest order since 2014. The cash crisis affecting the NHS has meant that few machines have been bought. Wikipedia
成立时间
2000
员工数量
24